FRANKFURT—Airbus plans to increase its research into how health-protection technology inside passenger aircraft cabins can be improved, the OEM’s executive vice president of engineering Jean-Brice Dumont told Aviation Week.

Embraer’s commercial operation has shifted focus to realign with the rest of the company and conserving cash, with new-product development—including a notional turboprop—put on hold while the business regains its footing amid the Boeing deal collapse and coronavirus crisis, Embraer Commercial Aviation president and CEO John Slattery said.

Boeing on April 30 filed regulatory notice that it could raise an undetermined amount of new debt financing through newly issued bonds, coming a day after the company’s chief executive outlined a grim outlook, albeit better than feared by the marketplace.

Tier-1 aerospace and defense systems and equipment supplier Safran is conducting a strong response to the pandemic’s consequences, in a bid to maintain financial balance.

Deutsche Regional Aircraft, the company behind the planned production restart of the Dornier 328 turboprop regional airliner, has hinted the latest version could introduce new propulsion technologies.

Airbus will not decide on further changes to its production rates before June and any potential adaptations will be “on a smaller scale” than previous cuts, Airbus CEO Guillaume Faury said April 29.

For all those who believe that things come in threes, there now is the third failed mergers and acquisition (M&A) deal attributable to COVID-19 in April alone.

Startup Skyryse is flight testing the software for the first application of its FlightOS automation system as it progresses toward certification of the aircraft-agnostic fly-by-wire (FBW) architecture on its first platform.